Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Ono Venture Investment: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Ono Venture Investment
Ono Venture Investment
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Ono Venture Investment.
HY
HIROSHI YAMAMOTO
President & CEO
SM
Shunichiro Matsumoto
CEO
Leadership Team
Key people at Ono Venture Investment.
HY
HIROSHI YAMAMOTO
President & CEO
SM
Shunichiro Matsumoto
CEO
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Sep 1, 2025
Alchemab Therapeutics
$32.0M Series A
—
RA Capital
,
SV Health Investors
,
DCVC Bio
, Mike Hutton
,
Lightstone Ventures
, RA Capital Management
, Kate Bingham
Jun 2, 2023
Violet Therapeutics
$10.6M Seed
Jonathan Behr
, Atsushi Usami
Meredith Fisher
, Shunichiro Matsumoto
Jun 1, 2023
Mozart Therapeutics
$25.0M Series A
ARCH Venture Partners
,
Soffinova Partners
Leaps by Bayer
,
MRL Ventures Fund
,
Takeda Ventures
, Lucio Iannone
, Jasmina Marjanovic
,
Alexandria Venture Investments
, Altitude Life Science Ventures
, Eli Lilly and Company
,
UPMC Enterprises
Mar 22, 2023
Curreio
$2.0M Series A
—
3S Capital
,
Asahi Kasei Pharma
, Takehiko Sawabe
,
DOJIN Capital
,
IKERUNippon Capital Partners
, Kamada
,
U-Tokyo Entrepreneur Supporter
Mar 1, 2023
Switch Therapeutics
$52.0M Series A
Insight Partners
, Alicia Iruzun Lafitte
Alta Partners
,
Astellas Venture Management
,
Longwood Fund
,
Bold Capital Partners
,
Digitalis Ventures
,
Dolby Family Ventures
, Eli Lilly and Company
, Freeflow Ventures
,
PhiFund Ventures
,
Upfront Ventures
Nov 1, 2022
Casma Therapeutics
$46.0M Series C
—
Astellas Venture Management
,
The Column Group
,
Third Rock Ventures
,
Amgen Ventures
, Hiromichi Kimura
,
Eisai
,
Euclidean Capital
,
Eventide Asset Management
,
Mirae Asset
, Tomotaka Okino
, Schroders Capital
Nov 9, 2021
Arbor Biotechnologies
$215.0M Series B
Frank Yu
, Chen Yu
, Temasek
ARCH Venture Partners
,
ArrowMark Partners
,
Deep Track Capital
,
GreatPoint Ventures
,
Illumina Ventures
, Janus Henderson Investors
,
Logos Capital
, Piper Heartland Healthcare Capital
,
Ridgeback Capital Investments
,
Section 32
, Surveyor Capital
,
Tao Capital Partners
,
Tekla Capital Management
, T. Rowe Price Associates
, Vertex
,
Woodline Partners
Aug 1, 2021
Immunitas Therapeutics
$58.0M Series B
Agent Capital
Alta Partners
,
Cofounders Capital
,
Domain Associates
,
Leaps by Bayer
,
Longwood Fund
,
Novartis Venture Fund
,
Providence Ventures
,
RA Capital
,
Section 32
, Netalie Nadivi
,
120 Capital
,
Alexandria Venture Investments
,
Evotec
, Brian Halak
,
Mirae Asset
, M Ventures
,
Novartis
,
NS Investment
,
Solasta Ventures
,
The Leukemia & Lymphoma Society
,
The Mark Foundation for Cancer Research